ArticleReproductive health2025
An exploratory study of patients' experiences with and reasons for using one virtual-only telecontraceptive platform in the United States in 2020-2021.
Article in Reproductive health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTelecontraception, whereby one uses a website or mobile application to access contraceptive care, has grown over time, with an increasing number of virtual-only platforms offering this service. There are limited data on user experiences with virtual-only telecontraception, particularly among first-time telecontraception users. The aim of this exploratory study was to understand individuals’ experiences receiving contraceptive services from one virtual-only telecontraceptive platform.
methodsIndividuals aged 18–49 years who had used the platform for contraceptive care for the first time between March 2020-December 2021 were eligible for our online survey. We calculated descriptive statistics, chi-square tests, and Fisher’s exact tests to assess background characteristics, reasons for platform use, methods requested and prescribed, and satisfaction.
resultsAmong the 244 participants in our sample, most were first-time telecontraceptive users of any platform (76.2%) and had previously used short-acting hormonal contraception (77.9%). One-third (36.5%) reported COVID-19 played a role in their decision to use the platform. Most used the platform for convenience (81.2%) and to save time (53.7%) or money (43.0%) by not visiting a clinic, and similar proportions reported convenience (81.2%), affordability (55.3%), and the ability to get the method quickly (52.9%) as features they liked best about the platform. Uninsured participants (versus insured) were more likely to report using the platform to avoid clinic fees; insured individuals (versus uninsured) to save time and avoid inconvenient clinic hours; students (versus non-students) and young people (aged 18–24 years versus older age groups) for privacy; and Black participants (versus other races/ethnicities) for convenience. Most participants were very or somewhat satisfied with the service (86.1%) and would use telecontraception again (82.4%).
conclusionsMost participants were satisfied with their virtual-only telecontraception experience and reported it was convenient and affordable. However, our exploratory study highlights potential disparities in accessing telecontraceptive services among first-time users of short-acting hormonal contraception, young people aged 18–24, minors, and those without insurance. Future research should explore what access needs telecontraceptive care may be addressing and what more is needed to improve access to contraceptive care in the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.